CRSP just cleared its Darvas Box top with momentum, volume, and trend all aligning.Seed System confirmation:
Darvas Box breakout at $56–58
Massive volume surge following insider/institutional buying (ARK, UBS, T. Rowe)
EMA stack bullish (9 > 21 > 50)
VWMA trending up, price riding the band
MACD bullish cross, RSI moving through 70
Setup:
Entry Zone: $60.00–62.00 (watch for pullback)
Stop Loss: $58.00
Target 1: $70.00
Target 2: $80.00+
Catalyst: Positive CTX310 gene therapy results (LDL & triglyceride drops up to 80%), and biotech sector strength. RS Rating now 85 — breakout quality.
Expecting a retest of the breakout before continuation. Strong long setup if biotech sector holds.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.